ENTERO THERAPEUTICS INC (ENTO)
Institutional ownership reported to the SEC as of Q2 2025, across 7 quarters.
9
Reporting holders
$47.6K
Reported value
0.0%
Held as options
+3
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | $14.6K | 36,560 | 0.00% | 6q | HELD |
| UBS Group AG | $8.2K | 20,552 | 0.00% | 3q | -64.5%-$15.0K |
| TWO SIGMA SECURITIES, LLC | $6.3K | 15,776 | 0.00% | new | NEW |
| JANE STREET GROUP, LLC | $5.1K | 12,730 | 0.00% | new | NEW |
| RENAISSANCE TECHNOLOGIES LLC | $5.0K | 12,500 | 0.00% | new | NEW |
| CITADEL ADVISORS LLC | $5.0K | 12,415 | 0.00% | new | NEW |
| Tower Research Capital LLC (TRC) | $2.0K | 5,064 | 0.00% | 7q | HELD |
| SBI Securities Co., Ltd. | $1.3K | 3,307 | 0.00% | 3q | HELD |
| BANK OF AMERICA CORP /DE/ | $17 | 42 | 0.00% | 5q | +5.0% |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2025 | 9 | $47.6K | 118,946 | 4 | 1 | 1 | 0.0% |
| Q1 2025 | 6 | $54.2K | 112,951 | 1 | 4 | 0 | 0.0% |
| Q4 2024 | 9 | $44.9K | 72,213 | 3 | 2 | 3 | 0.0% |
| Q3 2024 | 6 | $21.1K | 61,194 | 3 | 2 | 1 | 0.0% |
| Q2 2024 | 8 | $182.7K | 148,101 | 2 | 3 | 1 | 0.0% |
| Q1 2024 | 6 | $177.1K | 40,255 | 2 | 1 | 1 | 0.0% |
| Q4 2023 | 5 | $18.4K | 4,381 | 5 | 0 | 0 | 0.0% |